Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Supernus Pharmaceuticals
SUPN
$2.74B
| $3.33M | ﹤0.01% |
140,093
+46,651
| +50% | +$1.03M |
|
|
PGM
1677
DELISTED
iPath Series B Bloomberg Platinum Subindex Total ReturnSM ETN
PGM
| $3.33M | ﹤0.01% |
80,000
| – | – |
|
1678
Artisan Partners
APAM
$3B
| $3.32M | ﹤0.01% |
102,055
-55,040
| -35% | -$1.53M |
|
|
CONN
1679
DELISTED
Conn's Inc.
CONN
| $3.31M | ﹤0.01% |
327,887
-172,289
| -34% | -$1.14M |
|
1680
Astec Industries
ASTE
$991M
| $3.3M | ﹤0.01% |
71,313
+52,739
| +284% | +$2.16M |
|
1681
Integra LifeSciences
IART
$1.33B
| $3.3M | ﹤0.01% |
70,273
+17,722
| +34% | +$871K |
|
1682
ESCO Technologies
ESE
$7.79B
| $3.3M | ﹤0.01% |
39,046
+2,195
| +6% | +$173K |
|
1683
Reinsurance Group of America
RGA
$15.8B
| $3.29M | ﹤0.01% |
41,990
-9,500
| -18% | -$877K |
|
1684
RLI Corp
RLI
$5.83B
| $3.29M | ﹤0.01% |
80,018
+37,608
| +89% | +$1.48M |
|
|
RSX
1685
CALL
DELISTED
VanEck Russia ETF
RSX
| $3.28M | ﹤0.01% |
158,200
-90,500
| -36% | -$1.78M |
|
1686
Jabil
JBL
$35.3B
| $3.28M | ﹤0.01% |
102,221
-34,374
| -25% | -$989K |
|
|
CMD
1687
DELISTED
Cantel Medical Corporation
CMD
| $3.28M | ﹤0.01% |
74,153
-29,575
| -29% | -$1.1M |
|
|
TSE
1688
DELISTED
Trinseo
TSE
| $3.28M | ﹤0.01% |
147,962
-12,965
| -8% | -$265K |
|
1689
Regenxbio
RGNX
$688M
| $3.27M | ﹤0.01% |
88,963
-1,162
| -1% | -$43.3K |
|
|
AMED
1690
DELISTED
Amedisys
AMED
| $3.27M | ﹤0.01% |
16,483
-3,514
| -18% | -$655K |
|
1691
Korn Ferry
KFY
$4.25B
| $3.27M | ﹤0.01% |
106,486
-7,005
| -6% | -$200K |
|
1692
First Citizens BancShares
FCNCA
$25.4B
| $3.27M | ﹤0.01% |
8,060
-19
| -0.2% | -$6.96K |
|
1693
The GEO Group
GEO
$4.04B
| $3.26M | ﹤0.01% |
275,981
+150,737
| +120% | +$1.84M |
|
1694
Lazard
LAZ
$4.16B
| $3.26M | ﹤0.01% |
114,027
+112,280
| +6,427% | +$3.04M |
|
1695
PUT
Mattel
MAT
$4.21B
| $3.26M | ﹤0.01% |
336,900
-287,000
| -46% | -$2.61M |
|
|
TXNM
1696
TXNM Energy Inc
TXNM
$5.91B
| $3.24M | ﹤0.01% |
84,383
+34,938
| +71% | +$1.4M |
|
|
WIFI
1697
DELISTED
Boingo Wireless, Inc.
WIFI
| $3.24M | ﹤0.01% |
243,502
+18,574
| +8% | +$243K |
|
1698
MDU Resources
MDU
$4.29B
| $3.24M | ﹤0.01% |
384,121
-174,438
| -31% | -$1.45M |
|
1699
Donaldson
DCI
$11.2B
| $3.23M | ﹤0.01% |
69,544
+57,249
| +466% | +$2.53M |
|
1700
Canadian Pacific Kansas City
CP
$79.6B
| $3.23M | ﹤0.01% |
63,330
+26,835
| +74% | +$1.27M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.